Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05537766
What this trial is testing

Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies

Who this might be right for
Relapsed/Refractory Waldenstrom MacroglobulinemiaRelapsed/Refractory Richter TransformationRelapsed/Refractory Burkitt Lymphoma+1 more
Kite, A Gilead Company 19
Not applicableLooking for participantsNCT07720154
What this trial is testing

Hernia Sac Flap Coverage of Mesh in Bony-Edged Ventral Hernia Repair

Who this might be right for
Incisional HerniaAbdominal HerniaComplex Ventral Hernia+4 more
Minia University 180
Large-scale testing (Phase 3)Study completedNCT01321359
What this trial is testing

Study of NB-001 in the Treatment of Recurrent Herpes Labialis

Who this might be right for
Recurrent Herpes Simplex Labialis
NanoBio Corporation 907
Post-approval studies (Phase 4)Enrolling By InvitationNCT06636669
What this trial is testing

Probiotics in the Prevention of Recurrent Prosthetic Joint Infection of the Hip and Knee

Who this might be right for
Prosthetic-joint InfectionDysbiosis
Boston Medical Center 152
Testing effectiveness (Phase 2)Study completedNCT00096096
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00489203
What this trial is testing

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more
Fred Hutchinson Cancer Center 140
Not applicableLooking for participantsNCT04305808
What this trial is testing

Characterization of Vaginal, Urinary and Fecal Microbiomes in Women with Recurrent Urinary Tract Infections

Who this might be right for
Urinary Tract InfectionsMenopause
Hadassah Medical Organization 40
Very early researchStudy completedNCT03050515
What this trial is testing

Fecal Microbiota Transplantation for the Treatment of Recurrent Urinary Tract Infections

Who this might be right for
Recurrent Urinary Tract Infection
University of California, Irvine 12
Early research (Phase 1)Study completedNCT01478685
What this trial is testing

CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma, Transitional CellOvarian Neoplasms+5 more
Celgene 169
Not applicableNot Yet RecruitingNCT07600515
What this trial is testing

Evaluation of Persistent Infection by Oncogenic Human Papillomavirus (HPV) in Patients Treated for Cervical Carcinoma and Its Relation to Prognostic Factors

Who this might be right for
Locally Advanced Cervical CancerPrognostic Biomarker
Instituto do Cancer do Estado de São Paulo 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Not applicableEnded earlyNCT03557749
What this trial is testing

Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies

Who this might be right for
Immune and Microbial ReconstitutionSystemic Viral InfectionAcute-graft-versus-host Disease+5 more
Masonic Cancer Center, University of Minnesota 210
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Not applicableUnknownNCT05145101
What this trial is testing

Pneumococcal Vaccination in Patients With Chronic Lymphocytic Leukaemia

Who this might be right for
Pneumococcal InfectionsChronic Lymphocytic LeukemiaVaccine-Preventable Diseases+1 more
Hannah Garcia Garrido 150
Testing effectiveness (Phase 2)Study completedNCT00914745
What this trial is testing

Place Controlled Study to Treat Recurrent Herpes Labialis.

Who this might be right for
Recurrent Herpes Labialis
University of Zurich 40
Post-approval studies (Phase 4)Study completedNCT01018095
What this trial is testing

Trichomonas Vaginalis Recurrence Among HIV+ Women

Who this might be right for
Trichomonas InfectionsHIV Infections
Tulane University Health Sciences Center 270
Early research (Phase 1)Looking for participantsNCT07133997
What this trial is testing

Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent B Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia
City of Hope Medical Center 26
Testing effectiveness (Phase 2)Ended earlyNCT01116232
What this trial is testing

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Barbara Ann Karmanos Cancer Institute 4
Testing effectiveness (Phase 2)WithdrawnNCT00789464
What this trial is testing

Probiotics for Girls With Recurring Urinary Tract Infections

Who this might be right for
Recurrent Urinary Tract Infection
Baylor College of Medicine
Very early researchUnknownNCT04184414
What this trial is testing

The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies

Who this might be right for
B Acute Lymphoblastic LeukemiaMantle Cell LymphomaFollicular Lymphoma
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Next Page